The Celsus developer got Botkin.AI

The Medical System Screening company acting as the developer of the Celsus service of support of adoption of medical decisions (SSAMD), got 100% of the Intellodzhik company, provider of the decision for the analysis of pictures of bodies of a thorax on the basis of technologies of artificial intelligence of Botkin.AI. Now "Intellodzhik" headed one of co-owners of the operator of Celsus Kapninsky Artem. Earlier the company belonged to a conglomerate of the investors, as one of the key acted the "T-physician", Samvel Karapetyan. Changes in EGRYuL are reflected on December 6, 2023. JSC Meditsinskiye skrining sistemy...